Our five core research programs are investigating and developing treatments for a broad spectrum of cancer types including breast, bowel, liver, lung, melanoma, gastrointestinal and brain cancer.

Emerging discoveries from the laboratory are made available through trials for the benefit of cancer patients with Institute investigators overseeing 60-70 clinical trials any one time. Observations from the clinic are then investigated by our research team. We thereby create a continual cycle of learning and improvement between scientific research and care.

We are committed to the continual discovery, development and trial of breakthrough therapies in the fight against cancer.
The Hon. John Brumby, ONJCRI Chairman